Nyxoah Annonce la Signature d'un Mémorandum d'Accord avec l'Hôpital Sheikh Shakhbout Medical City afin d'Améliorer la Prise en Charge du Traitement de l'AOS et [...] Read more »
Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East
Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East
Read more »
Nyxoah Fera une Présentation lors de la 44ème Conférence Annuelle J.P. Morgan Healthcare
Nyxoah Fera une Présentation lors de la 44ème Conférence Annuelle J.P. Morgan Healthcare
Mont–Saint–Guibert, Belgique – 29 [...] Read more »
Nyxoah to Present at the 44th Annual J.P. Morgan Healthcare Conference
Nyxoah to Present at the 44th Annual J.P. Morgan Healthcare Conference
Mont–Saint–Guibert, Belgium – December 29, 2025, 10:05pm CET / 4:05pm ET [...] Read more »
Nyxoah Announces Issuance of First Tranche of Convertible Bonds
Nyxoah Announces Issuance of First Tranche of Convertible Bonds
Mont–Saint–Guibert, Belgium – December 19, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext [...] Read more »
Nyxoah Annonce L’Émission de la Première Tranche des Obligations Convertibles
Nyxoah Annonce L’Émission de la Première Tranche des Obligations Convertibles
Mont–Saint–Guibert, Belgique – 19 décembre 2025, [...] Read more »
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands
First Genio implants successfully performed at OLVG West and Zuyderland hospitals
Read more »
Nyxoah Annonce le Lancement Commercial de la Thérapie Innovante Genio® Aux Pays-Bas
Nyxoah Annonce le Lancement Commercial de la Thérapie Innovante Genio® Aux Pays–Bas
Premières implantations Genio réalisées avec succès dans les hôpitaux [...] Read more »
Publication relating to transparency notifications
Publication relative à des notifications de transparence
INFORMATION RÉGLEMENTÉE
Publication relative à des notifications de transparence
Read more »
Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference
Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference
Mont–Saint–Guibert, Belgium – 27 [...] Read more »
Nyxoah Participera à la Piper Sandler 37th Annual Healthcare Conference
Nyxoah Participera à la Piper Sandler 37th Annual Healthcare Conference
Mont–Saint–Guibert, Belgique – [...] Read more »
Nyxoah’s Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule
Nyxoah’s Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule
Assignment to New Technology APC 1580 is positive news for [...] Read more »
La Thérapie Genio® de Nyxoah Bénéficie d'une Augmentation Significative du Remboursement Medicare en 2026 en Vertu de la Règle Finale du CMS
La Thérapie Genio® de Nyxoah Bénéficie d'une Augmentation Significative du Remboursement Medicare en 2026 en Vertu de la Règle Finale du CMS
Read more »
Information on the total number of voting rights and shares
REGULATED INFORMATION
Information on the total number of voting rights and shares
Mont–Saint–Guibert [...] Read more »